Is Cardinal Health (CAH) a Great Value Stock Right Now?

27.05.26 15:40 Uhr

Werte in diesem Artikel
Aktien

209,50 EUR 0,40 EUR 0,19%

Indizes

7.499,4 PKT 58,9 PKT 0,79%

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.One company value investors might notice is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 15.48 right now. For comparison, its industry sports an average P/E of 15.74. Over the past 52 weeks, CAH's Forward P/E has been as high as 20.15 and as low as 13.69, with a median of 15.30. CAH is also sporting a PEG ratio of 1.24. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CAH's industry currently sports an average PEG of 1.81. Over the past 52 weeks, CAH's PEG has been as high as 1.88 and as low as 1.22, with a median of 1.49.Finally, our model also underscores that CAH has a P/CF ratio of 15.27. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 16.55. Within the past 12 months, CAH's P/CF has been as high as 17.47 and as low as 12.96, with a median of 15.12.These are just a handful of the figures considered in Cardinal Health's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that CAH is an impressive value stock right now.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.See Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Cardinal Health Inc.

Analysen zu Cardinal Health Inc.

DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst
03.11.2015Cardinal Health BuyUBS AG
03.11.2015Cardinal Health OutperformFBR Capital
09.06.2015Cardinal Health BuyUBS AG
10.03.2015Cardinal Health OutperformFBR Capital
04.03.2015Cardinal Health OutperformRBC Capital Markets
DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen